Genetic developmental and epileptic encephalopathy: genes and variants
Explore variant evidence for Genetic developmental and epileptic encephalopathy across 17 analyzed proteins (SCN1A, PPP2R5D, HCN1, KCNQ2, STXBP1 and 12 more). Linked ClinVar records include 3 pathogenic or likely pathogenic variants, 7 variants of uncertain significance and 3 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Genetic developmental and epileptic encephalopathy
SCN1A: Sodium channel protein type 1 subunit alpha
Its sodium current is especially important for reliable firing of inhibitory interneurons and therefore for balancing excitation across neural networks. Loss-of-function variants are the major cause of Dravet syndrome, while other variants cause GEFS+ or familial hemiplegic migraine.
2 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SCN1A have source records linked to Genetic developmental and epileptic encephalopathy. Association strength is not clinical gene validity.
PPP2R5D: Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform
It directs the PP2A phosphatase toward specific signaling substrates in neurons and other cells, helping control phosphorylation-dependent growth and synaptic pathways. De novo pathogenic variants cause Jordan's syndrome, with developmental delay, intellectual disability, hypotonia, and often macrocephaly.
1 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in PPP2R5D have source records linked to Genetic developmental and epileptic encephalopathy. Association strength is not clinical gene validity.
HCN1: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1
The protein forms a hyperpolarization-activated channel that conducts both potassium and sodium ions. It contributes to pacemaker currents and the neuronal I(h) current that shapes excitability, and HCN1 variants are associated with developmental epilepsy syndromes.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in HCN1 have source records linked to Genetic developmental and epileptic encephalopathy. Association strength is not clinical gene validity.
KCNQ2: Potassium voltage-gated channel subfamily KQT member 2
Together with KCNQ3, its slowly activating potassium current provides much of the neuronal M-current that suppresses repetitive firing. Pathogenic variants cause a spectrum from self-limited familial neonatal epilepsy to severe developmental and epileptic encephalopathy.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in KCNQ2 have source records linked to Genetic developmental and epileptic encephalopathy. Association strength is not clinical gene validity.
STXBP1: Syntaxin-binding protein 1
It controls SNARE-complex assembly and synaptic-vesicle fusion, making it essential for rapid neurotransmitter release. Haploinsufficiency causes STXBP1-related neurodevelopmental disorder with developmental impairment, epilepsy, movement abnormalities, and intellectual disability.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in STXBP1 have source records linked to Genetic developmental and epileptic encephalopathy. Association strength is not clinical gene validity.
ATP6V1A: V-type proton ATPase catalytic subunit A
It provides ATP-hydrolyzing activity to the vacuolar proton pump, driving acidification of endosomes, lysosomes, and secretory vesicles. De novo pathogenic variants can cause developmental encephalopathy with epilepsy and intellectual disability.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in ATP6V1A have source records linked to Genetic developmental and epileptic encephalopathy. Association strength is not clinical gene validity.
SMC1A: Structural maintenance of chromosomes protein 1A
A core cohesin protein that helps hold sister chromatids together and organize DNA. Variants can cause Cornelia de Lange syndrome or developmental epilepsy.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SMC1A have source records linked to Genetic developmental and epileptic encephalopathy. Association strength is not clinical gene validity.
CACNA1E: Voltage-dependent R-type calcium channel subunit alpha-1E
It contributes R-type calcium current at neuronal membranes and presynaptic terminals, shaping neurotransmitter release and neuronal firing. De novo pathogenic variants can cause severe developmental and epileptic encephalopathy with movement abnormalities.
0 ClinVar pathogenic / likely pathogenic and 2 uncertain variants in CACNA1E have source records linked to Genetic developmental and epileptic encephalopathy. Association strength is not clinical gene validity.
NTRK2: BDNF/NT-3 growth factors receptor
BDNF and neurotrophin-4 signaling through this pathway promotes neuronal survival, synaptic plasticity, and circuit maturation. Rare germline variants can cause neurodevelopmental or metabolic phenotypes, while oncogenic NTRK2 fusions can drive diverse cancers.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in NTRK2 have source records linked to Genetic developmental and epileptic encephalopathy. Association strength is not clinical gene validity.
SYNJ1: Polyphosphatidylinositol phosphatase SYNJ1
It remodels phosphoinositides during clathrin-mediated synaptic-vesicle recycling and helps nerve terminals rapidly regenerate release-ready vesicles. Biallelic pathogenic variants can cause early-onset parkinsonism or severe developmental and epileptic encephalopathy.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SYNJ1 have source records linked to Genetic developmental and epileptic encephalopathy. Association strength is not clinical gene validity.
GABRG2: Gamma-aminobutyric acid receptor subunit gamma-2
The gene product supplies the gamma-2 subunit of synaptic GABA-A receptors, which are pentameric chloride channels activated by the inhibitory neurotransmitter GABA. The subunit helps receptor assembly and localization at neuronal membranes, and GABRG2 variants are associated with several epilepsy syndromes.
0 ClinVar pathogenic / likely pathogenic and 2 uncertain variants in GABRG2 have source records linked to Genetic developmental and epileptic encephalopathy. Association strength is not clinical gene validity.
SCN2A: Sodium channel protein type 2 subunit alpha
The protein forms Nav1.2, a voltage-gated sodium channel that carries sodium current during neuronal action potentials. By shaping neuronal excitability and signal propagation, it supports brain circuits involved in development, learning, and seizure susceptibility.
0 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in SCN2A have source records linked to Genetic developmental and epileptic encephalopathy. Association strength is not clinical gene validity.
CACNA2D2: Voltage-dependent calcium channel subunit alpha-2/delta-2
It promotes trafficking and functional expression of voltage-gated calcium-channel complexes and is particularly important in cerebellar neurons. Biallelic loss-of-function variants can cause developmental epileptic encephalopathy with cerebellar atrophy and ataxia.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in CACNA2D2 have source records linked to Genetic developmental and epileptic encephalopathy. Association strength is not clinical gene validity.
KCNA2: Potassium voltage-gated channel subfamily A member 2
Its current helps repolarize neuronal membranes and regulate action-potential firing and neurotransmitter release. Both loss- and gain-of-function variants can cause developmental and epileptic encephalopathy, often with ataxia, movement abnormalities, or intellectual disability.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in KCNA2 have source records linked to Genetic developmental and epileptic encephalopathy. Association strength is not clinical gene validity.
KCNB1: Potassium voltage-gated channel subfamily B member 1
Its delayed-rectifier current contributes to neuronal repolarization and also participates in activity-dependent signaling complexes at the membrane. De novo pathogenic variants are an important cause of developmental and epileptic encephalopathy with intellectual disability and variable seizures.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in KCNB1 have source records linked to Genetic developmental and epileptic encephalopathy. Association strength is not clinical gene validity.
SCN1B: Sodium channel regulatory subunit beta-1
The beta-1 subunit of voltage-gated sodium channels, which regulates channel activity and cell adhesion. Pathogenic variants cause several forms of epilepsy, while associations with cardiac arrhythmias have also been reported.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SCN1B have source records linked to Genetic developmental and epileptic encephalopathy. Association strength is not clinical gene validity.
SCN8A: Sodium channel protein type 8 subunit alpha
The protein forms Nav1.6, a voltage-gated sodium channel that sets the threshold and propagation of neuronal action potentials. It is widely important for neuronal excitability, and SCN8A variants are associated with developmental and epileptic encephalopathies.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SCN8A have source records linked to Genetic developmental and epileptic encephalopathy. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): ANGPTL3, ATRX, CEP290, CHD8, MED13L, RYR3, SETD2 and ZFHX3.
ClinVar pathogenic and likely pathogenic variants linked to Genetic developmental and epileptic encephalopathy
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| SCN1A R219T | 219 | I | Pathogenic / likely pathogenic (★★★) |
| SCN1A R219G | 219 | I | Pathogenic / likely pathogenic (★★★) |
| PPP2R5D W207R | 207 | Pathogenic / likely pathogenic (★★) |
Same protein, different disease
- Early-infantile DEE also has ClinVar records linked to SCN1A variants; they fall mostly in different places as the Genetic developmental and epileptic encephalopathy variants (422 pathogenic / likely pathogenic).
- Severe myoclonic epilepsy in infancy also has ClinVar records linked to SCN1A variants; they fall mostly in different places as the Genetic developmental and epileptic encephalopathy variants (213 pathogenic / likely pathogenic).
- Generalized epilepsy with febrile seizures plus also has ClinVar records linked to SCN1A variants; they fall mostly in different places as the Genetic developmental and epileptic encephalopathy variants (76 pathogenic / likely pathogenic).
- Developmental and epileptic encephalopathy also has ClinVar records linked to SCN1A variants; they fall mostly in different places as the Genetic developmental and epileptic encephalopathy variants (46 pathogenic / likely pathogenic).
- Familial hemiplegic migraine also has ClinVar records linked to SCN1A variants; they fall mostly in different places as the Genetic developmental and epileptic encephalopathy variants (20 pathogenic / likely pathogenic).
- Hogue-Janssens syndrome 1 also has ClinVar records linked to PPP2R5D variants; they fall mostly in different places as the Genetic developmental and epileptic encephalopathy variants (14 pathogenic / likely pathogenic).
Diseases related to Genetic developmental and epileptic encephalopathy
- Developmental and epileptic encephalopathy, also linked to ATP6V1A, CACNA1E, CACNA2D2, GABRG2 and 11 more
- Epilepsy, also linked to CACNA1E, CACNA2D2, GABRG2, KCNQ2 and 4 more
- Early-infantile DEE, also linked to CACNA2D2, HCN1, KCNQ2, SCN1A and 2 more
- Generalized epilepsy with febrile seizures plus, also linked to GABRG2, HCN1, SCN1A and SCN1B
- Migraine, also linked to GABRG2, SCN1A, SCN2A and SCN8A
- Lennox-Gastaut syndrome, also linked to GABRG2, SCN1A, SCN2A and SCN8A
- Undetermined early-onset epileptic encephalopathy, also linked to HCN1, KCNA2, KCNB1 and SCN8A
- Seizures, benign familial, also linked to KCNQ2, SCN2A and SCN8A
- Amyotrophic lateral sclerosis, also linked to SCN1A, SCN2A and SCN8A
- Cardiac arrhythmia, also linked to SCN1A, SCN2A and SCN8A
- Complex neurodevelopmental disorder, also linked to KCNA2, SCN2A and SCN8A
- Spasms, also linked to KCNQ2, SCN2A and SCN8A
Frequently asked questions
Which genes have records linked to Genetic developmental and epileptic encephalopathy?
This view contains 17 analyzed proteins: SCN1A, PPP2R5D, HCN1, KCNQ2, STXBP1 and 12 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 3 pathogenic or likely pathogenic variants, 7 variants of uncertain significance and 3 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 301 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center